Literature DB >> 2190426

Expert systems in treating substance abuse.

D R Wesson1, R H Hink.   

Abstract

Computer programs can assist humans in solving complex problems that cannot be solved by traditional computational techniques using mathematic formulas. These programs, or "expert systems," are commonly used in finance, engineering, and computer design. Although not routinely used in medicine at present, medical expert systems have been developed to assist physicians in solving many kinds of medical problems that traditionally require consultation from a physician specialist. No expert systems are available specifically for drug abuse treatment, but at least one is under development. Where access to a physician specialist in substance abuse is not available for consultation, this expert system will extend specialized substance abuse treatment expertise to nonspecialists. Medical expert systems are a developing technologic tool that can assist physicians in practicing better medicine.

Entities:  

Mesh:

Year:  1990        PMID: 2190426      PMCID: PMC1002415     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  2 in total

1.  DXplain. An evolving diagnostic decision-support system.

Authors:  G O Barnett; J J Cimino; J A Hupp; E P Hoffer
Journal:  JAMA       Date:  1987-07-03       Impact factor: 56.272

2.  Internist-1, an experimental computer-based diagnostic consultant for general internal medicine.

Authors:  R A Miller; H E Pople; J D Myers
Journal:  N Engl J Med       Date:  1982-08-19       Impact factor: 91.245

  2 in total
  2 in total

1.  Using ILIAD system shell to create an expert system for differential diagnosis of renal masses.

Authors:  P L Chang; Y C Li; C J Wu; M H Huang
Journal:  J Med Syst       Date:  1993-10       Impact factor: 4.460

2.  Computer-aided DSM-IV-diagnostics - acceptance, use and perceived usefulness in relation to users' learning styles.

Authors:  Lars G Bergman; Uno G H Fors
Journal:  BMC Med Inform Decis Mak       Date:  2005-01-07       Impact factor: 2.796

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.